The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

According to The Business Research Company’s report, the global flow cytometry market in oncology and immunology is projected to increase from $1.70 billion in 2022 to $1.89 billion in 2023, with a CAGR of 11.03%. Furthermore, the market is anticipated to achieve $2.79 billion in 2027, growing at a CAGR of 10.2%.

What was the major driver in the flow cytometry in oncology and immunology market?
The surge in cancer cases is expected to drive the growth of flow cytometry in the oncology and immunology sectors. Cancer encompasses a range of disorders characterized by uncontrolled cell growth and spread. Flow cytometry is a widely utilized technique in oncology and immunology for analyzing cancer and immune cells. For instance, Macmillan Cancer Support, a UK-based healthcare charity organization, reported 3 million cancer cases in 2020, with projections of 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Hence, the rising cancer prevalence fuels the expansion of flow cytometry in the oncology and immunology markets.

View More On The Flow Cytometry In Oncology And Immunology Market Report 2023 – https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

What was the key trend in the flow cytometry in oncology and immunology market?
Technological advancements are a prominent trend in flow cytometry within the oncology and immunology sectors. Leading companies in these markets are adopting novel technologies to maintain their competitive positions. As an illustration, in September 2022, Becton Dickinson and Company, a U.S.-based medical technology provider, introduced BD Research Cloud for flow cytometry in oncology and immunology. BD Cloud is a cloud-based software system simplifying the flow cytometry process for researchers across various fields, including immunology, virology, infectious disease, and oncology surveillance. This enhances the quality and expedites insights in their studies. BD leverages innovative technologies like BD Horizon RealYellow and RealBlue Reagents, as well as the newly introduced BD FACSDiscover S8 Cell Sorter with BD CellView Image Technology, boosting the potential of flow cytometry. This empowers researchers to optimize and advance their groundbreaking studies. BD Research Cloud is built on an industry-standard cloud infrastructure and aligns perfectly with BD equipment and reagents.

Which was the largest region in the flow cytometry in oncology and immunology market?
North America was the largest region in the flow cytometry in oncology and immunology market in 2022. The regions covered in flow cytometry in oncology and immunology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the flow cytometry in oncology and immunology market prominent players?
Major players in the flow cytometry in oncology and immunology market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, Enzi Biochem Inc., DiaSorin S.p.A,BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, and CytoReason.

Key flow cytometry in oncology and immunology market segments
The global flow cytometry in oncology and immunology market is segmented –
1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users

Request A Sample Of The Global Flow Cytometry In Oncology And Immunology Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12469&type=smp

The Flow Cytometry In Oncology And Immunology Global Market Report 2023  provides a comprehensive overview on the flow cytometry in oncology and immunology market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Interventional Oncology Devices Global Market Report 2023
Oncology Devices Global Market Report 2023
Flow Cytometry Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model